## GPN: Global Payments Inc. - XLI: Industrials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.2% in lower entry zone (3.0-6.0%), top quartile (81st pct) cross-sectional ranking. Short-term MRS_5 (1.0%) confirms momentum alignment. Strong momentum (+1.1% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($77.22)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Global Payments Inc. Stock Advances 2.5%, Outperforms Competitors**
- Source: 富途牛牛 | 20251216T200837 | Bullish | Relevance: 100%
- Global Payments Inc. (GPN) saw its stock advance by 2.5%, outperforming its competitors. Simultaneously, Unity Software (U.US) reported its Q4 financial results, with revenue increasing 35% year-over-year to $609 million, exceeding analyst estimates, despite reporting a quarterly loss of 66 cents per share.

**2. FORA Capital LLC Makes New $4.11 Million Investment in Global Payments Inc. $GPN**
- Source: MarketBeat | 20251214T091644 | Somewhat-Bullish | Relevance: 96%
- FORA Capital LLC recently acquired a new stake in Global Payments Inc. (NYSE:GPN) worth approximately $4.11 million during the second quarter. Other hedge funds have also adjusted their holdings in GPN, and analysts have reaffirmed a bullish outlook for the stock. Global Payments reported strong Q3 earnings and announced a quarterly dividend of $0.25, with institutional investors and hedge funds owning a significant portion of the stock.

**3. Hedge Fund and Insider Trading News: AQR Capital Management, Bridgewater Associates, Shiprock Capital Management, Totus Capital, Sage Capital, Global Payments Inc (GPN), FibroBiologics Inc. (FBLG), and More**
- Source: Insider Monkey | 20251215T190904 | Neutral | Relevance: 80%
- This article covers recent news in the hedge fund and insider trading world, featuring major firms like AQR Capital Management and Bridgewater Associates, alongside insights into specific stock movements. Key topics include Bridgewater's warning about Big Tech's AI funding, AQR's asset growth, and insider buying in Global Payments Inc (GPN) and FibroBiologics Inc. (FBLG). The report also highlights hedge funds' increasing interest in commodities and their continuous net buying streak in U.S. stocks.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 5 ($0.92M) |
| Sells | 3 ($1.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.9% (+0.6%)
- Blackrock Inc.: 8.4% (+3.6%)
- Pzena Investment Man: 4.6% (-1.3%)
- State Street Corpora: 4.4% (-1.4%)
- Synovus Financial Co: 3.2% (-0.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +1.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.57 indicates undervaluation relative to growth. Forward P/E 6.0x attractive for 12% earnings growth. Quality metrics strong (margin 17%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.8B |
| Beta | 0.82 |
| 52W Range | $65.93 - $116.16 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.57 |
| Forward P/E | 6.0 |
| Current P/E | 6.7 |
| YoY Growth | 12.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 2.2% to 3.2% (+1.1% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 81st percentile. MRS_5 at 1.0% confirms short-term momentum alignment. Below SMA200 (0.98x), long-term trend not supportive. MACD histogram positive (0.83), confirming momentum. RSI neutral at 60. OFD pattern: -SBN (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.22% (CS: 81) | Strong |
| RSI_14 | 59.9 | Neutral |
| MACD Histogram | 0.83 | Bullish |
| vs SMA20 | 1.056x | Above |
| vs SMA50 | 1.018x | Above |
| vs SMA200 | 0.982x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $81.44
- **Stop Loss:** $77.22 (5.2% risk)
- **Target:** $87.77 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 284
- **Position Value:** $23,128.96
- **Portfolio %:** 23.13%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-02-12 (Est: $3.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.23 | $3.26 | +0.8% |
| 2025Q2 | $3.06 | $3.10 | +1.5% |
| 2025Q1 | $2.72 | $2.69 | -1.0% |
| 2024Q4 | $2.96 | $2.95 | -0.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*